Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Prepaid Assets (2021 - 2025)

Krystal Biotech (KRYS) has disclosed Prepaid Assets for 5 consecutive years, with $14.0 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 766.17% to $14.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.0 million through Dec 2025, up 766.17% year-over-year, with the annual reading at $14.0 million for FY2025, 766.17% up from the prior year.
  • Prepaid Assets hit $14.0 million in Q4 2025 for Krystal Biotech, down from $17.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $17.2 million in Q3 2025 to a low of $1.6 million in Q4 2024.
  • Historically, Prepaid Assets has averaged $7.0 million across 5 years, with a median of $5.3 million in 2023.
  • Biggest five-year swings in Prepaid Assets: crashed 75.89% in 2024 and later skyrocketed 766.17% in 2025.
  • Year by year, Prepaid Assets stood at $4.2 million in 2021, then increased by 10.48% to $4.6 million in 2022, then surged by 45.53% to $6.7 million in 2023, then plummeted by 75.89% to $1.6 million in 2024, then surged by 766.17% to $14.0 million in 2025.
  • Business Quant data shows Prepaid Assets for KRYS at $14.0 million in Q4 2025, $17.2 million in Q3 2025, and $16.9 million in Q2 2025.